Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Burrell

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Drug Safety|January 1, 1997
A risk-benefit assessment of losartan potassium in the treatment of hypertensionL M Burrell
The Journal of Nutrition, Health & Aging|September 20, 2000
Thirst in elderly subjectsM Naitoh, L M Burrell
The Medical Journal of Australia|June 19, 1995
Beyond ACE inhibition: new developments in drug therapy for hypertensionL M Burrell, C I Johnston
Australian Family Physician|July 1, 1993
Angiotensin converting enzyme inhibitors in perspective: an updateL M Burrell, C I Johnston
Trends in Endocrinology and Metabolism: TEM|July 4, 2001
Endocrinology and metabolism meet in the heartL M Burrell, J W Funder
Clinical Endocrinology|April 1, 1990
Release of atrial natriuretic peptide during hypertonic saline infusion: the importance of postureL M Burrell, P H Baylis
Drugs & Aging|June 1, 1997
Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular diseaseL M Burrell, C I Johnston
Journal of Human Hypertension|June 1, 1995
Evolution of blockade of the renin-angiotensin systemC I Johnston, L M Burrell
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 9, 1998
Rationale and pharmacology of angiotensin II receptor antagonists: current status and future issuesC I Johnston, M Naitoh, L M Burrell
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1993
Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosteroneA M Abdelrahman, L M Burrell, C I Johnston
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Drug Safety|January 1, 1997
A risk-benefit assessment of losartan potassium in the treatment of hypertensionL M Burrell
The Journal of Nutrition, Health & Aging|September 20, 2000
Thirst in elderly subjectsM Naitoh, L M Burrell
The Medical Journal of Australia|June 19, 1995
Beyond ACE inhibition: new developments in drug therapy for hypertensionL M Burrell, C I Johnston
Australian Family Physician|July 1, 1993
Angiotensin converting enzyme inhibitors in perspective: an updateL M Burrell, C I Johnston
Trends in Endocrinology and Metabolism: TEM|July 4, 2001
Endocrinology and metabolism meet in the heartL M Burrell, J W Funder
Clinical Endocrinology|April 1, 1990
Release of atrial natriuretic peptide during hypertonic saline infusion: the importance of postureL M Burrell, P H Baylis
Drugs & Aging|June 1, 1997
Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular diseaseL M Burrell, C I Johnston
Journal of Human Hypertension|June 1, 1995
Evolution of blockade of the renin-angiotensin systemC I Johnston, L M Burrell
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 9, 1998
Rationale and pharmacology of angiotensin II receptor antagonists: current status and future issuesC I Johnston, M Naitoh, L M Burrell
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 1, 1993
Blockade of the renin-angiotensin system at different sites: effect on renin, angiotensin and aldosteroneA M Abdelrahman, L M Burrell, C I Johnston
Pageof 9